Read + Share
Claudiani S, Apperley JF, Szydlo R, Khan A, et al. TKI dose reduction can effectively maintain major molecular remission in patients
with chronic myeloid leukaemia. Br J Haematol 2021;193:346-355.
PMID: 33368155
|
 |
|
Claudiani S, Apperley JF, Szydlo R, Khan A, et al. TKI dose reduction can effectively maintain major molecular remission in patients
with chronic myeloid leukaemia. Br J Haematol 2021;193:346-355.
PMID: 33368155
|
|
|
|